Midatech Pharma PLC - ESG Rating & Company Profile powered by AI
Comprehensive ESG assessment of Midatech Pharma PLC are accessed by registering for free. Check the bottom of this page for potential risks for Midatech Pharma PLC based on sector, geography and marketcap. This dashboard contains a questions and answers table about Midatech Pharma PLC.
Midatech Pharma PLC in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.4; made up of an environmental score of 2.7, social score of 3.2 and governance score of 4.0.
3.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1617 | VistaGen Therapeutics Inc | 3.5 | Medium |
| 1617 | Yumanity Therapeutics Inc | 3.5 | Medium |
| 1659 | Midatech Pharma PLC | 3.4 | Medium |
| 1659 | Acceleron Pharma Inc | 3.4 | Medium |
| 1659 | Annexin Pharmaceuticals AB (publ) | 3.4 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Midatech Pharma PLC have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Midatech Pharma PLC disclose current and historical energy intensity?
Sign up for free to unlockDoes Midatech Pharma PLC report the average age of the workforce?
Sign up for free to unlockDoes Midatech Pharma PLC reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Midatech Pharma PLC disclose its ethnicity pay gap?
Sign up for free to unlockDoes Midatech Pharma PLC disclose cybersecurity risks?
Sign up for free to unlockDoes Midatech Pharma PLC offer flexible work?
Sign up for free to unlockDoes Midatech Pharma PLC have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Midatech Pharma PLC disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Midatech Pharma PLC conduct supply chain audits?
Sign up for free to unlockDoes Midatech Pharma PLC disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Midatech Pharma PLC conduct 360 degree staff reviews?
Sign up for free to unlockDoes Midatech Pharma PLC disclose the individual responsible for D&I?
Sign up for free to unlockDoes Midatech Pharma PLC disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Midatech Pharma PLC disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Midatech Pharma PLC disclose water use targets?
Sign up for free to unlockDoes Midatech Pharma PLC have careers partnerships with academic institutions?
Sign up for free to unlockDid Midatech Pharma PLC have a product recall in the last two years?
Sign up for free to unlockDoes Midatech Pharma PLC disclose incidents of discrimination?
Sign up for free to unlockDoes Midatech Pharma PLC allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Midatech Pharma PLC issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Midatech Pharma PLC disclose parental leave metrics?
Sign up for free to unlockDoes Midatech Pharma PLC disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Midatech Pharma PLC disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Midatech Pharma PLC disclose the pay ratio of women to men?
Sign up for free to unlockDoes Midatech Pharma PLC support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Midatech Pharma PLC disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Midatech Pharma PLC reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Midatech Pharma PLC involved in embryonic stem cell research?
Sign up for free to unlockDoes Midatech Pharma PLC disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Midatech Pharma PLC disclose its waste policy?
Sign up for free to unlockDoes Midatech Pharma PLC report according to TCFD requirements?
Sign up for free to unlockDoes Midatech Pharma PLC disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Midatech Pharma PLC disclose energy use targets?
Sign up for free to unlockDoes Midatech Pharma PLC disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Midatech Pharma PLC have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Midatech Pharma PLC
These potential risks are based on the size, segment and geographies of the company.
Midatech Pharma plc, a drug delivery technology company, focuses on the research and development of medicines in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTD219, a long-acting formulation of tacrolimus used to lower the risk of organ transplant rejection. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.